NCT03755583

Brief Summary

Inflammatory bowel diseases (IBD) are chronic inflammatory diseases. It is believed that the inflammation results from sustained abnormal immune response towards altered or pathogenic microbiota in genetically susceptible hosts. Malnutrition is common in IBD, especially in pediatric Crohn's disease(CD). Exclusive enteral nutrion(EEN) has been shown to improve nutritional status and inflammatory markers in pediatric CD. But there is limited data about the effect of EEN on Chinese children with CD. In this study, investigators focused on disease process,nutritional status and gut microbiome of Chinese children with newly-diagnosed CD after EEN treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

November 18, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 28, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

January 27, 2020

Status Verified

January 1, 2020

Enrollment Period

2.9 years

First QC Date

November 18, 2018

Last Update Submit

January 23, 2020

Conditions

Keywords

Exclusive enteral nutrition

Outcome Measures

Primary Outcomes (2)

  • 5-item gut microbiota measure

    the change of gut microbiota during EEN and after the end of EEN

    0, 2, 6, 8, 12 weeks post-EEN

  • 2-item Simple Endoscopic Score for CD (SES-CD)

    According to the SES-CD, at the end of EEN, the patients whose SES-CD scores were ≤4 were classified into the remission group (CD-RE), other patients whose SES-CD scores were \>4 were classified into the non-remission group (CD-NRE)

    0, 8, weeks post-EEN

Secondary Outcomes (7)

  • 5-item weighted Paediatric Crohn's disease activity index measure(wPCDAI)

    0, 2, 6, 8, 12 weeks post-EEN

  • 2-item 25-hydroxyvitamin D3 measure (25-OH VITD3)

    0,8 weeks post-EEN

  • 5-item weight measure

    0, 2, 6, 8, 12 weeks post-EEN

  • 5-item height measure

    0, 2, 6, 8, 12 weeks post-EEN

  • 5-item Fecal Calprotectin

    0, 2, 6, 8, 12 weeks post-EEN

  • +2 more secondary outcomes

Study Arms (1)

EEN group

OTHER

Received exclusive enteral nutrition after enrollment.

Dietary Supplement: Exclusive Enteral Nutrition

Interventions

Exclusive Enteral NutritionDIETARY_SUPPLEMENT

a complete liquid diet of formula for 8 weeks were adminstered in Crohn's Diseas patients ,Nutritional intake was based on the child's estimated energy requirements, no regular table food during 8 weeks treament.

EEN group

Eligibility Criteria

Age1 Year - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric CD patients who were newly diagnosed and being treated with EEN at the Children's Hospital of Fudan University

You may not qualify if:

  • (1) patients who were administered corticosteroids, immunosuppressive drugs, or biological agents prior to the study; (2) patients who could not finish the daily prescribed volume of formula for any reason; (3) patients who could not attend consecutive follow-up sessions; (4) patients who had received antibiotics or probiotics within 1.5 months prior to the study; and (5) patients who had been given corticosteroids, immunosuppressive drugs, biological agents, antibiotics, or probiotics during the EEN process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's hospital of Fudan university

Shanghai, Shanghai Municipality, 201102, China

Location

MeSH Terms

Conditions

Crohn Disease

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The director of gastroenterology of Children's Hospital of Fudan University

Study Record Dates

First Submitted

November 18, 2018

First Posted

November 28, 2018

Study Start

February 1, 2017

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

January 27, 2020

Record last verified: 2020-01

Locations